Verdence Capital Advisors’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.36M Buy
13,851
+11,260
+435% +$3.55M 0.23% 103
2026
Q1
$851K Buy
2,591
+84
+3% +$30.2K 0.05% 325
2025
Q4
$881K Sell
2,507
-754
-23% -$275K 0.05% 303
2025
Q3
$1.25M Buy
3,261
+1,746
+115% +$675K 0.07% 264
2025
Q2
$599K Buy
1,515
+22
+1% +$8.23K 0.04% 361
2025
Q1
$556K Sell
1,493
-71
-5% -$27K 0.04% 350
2024
Q4
$563K Sell
1,564
-57
-4% -$21.1K 0.05% 338
2024
Q3
$586K Buy
1,621
+268
+20% +$92.5K 0.05% 341
2024
Q2
$460K Buy
1,353
+231
+21% +$78.2K 0.04% 361
2024
Q1
$402K Buy
1,122
+105
+10% +$35.3K 0.04% 389
2023
Q4
$305K Hold
1,017
0.03% 459
2023
Q3
$278K Buy
1,017
+86
+9% +$24.7K 0.03% 461
2023
Q2
$284K Buy
+931
New +$269K 0.03% 432

Other funds holding SYK

Verdence Capital Advisors's SYK Position: Q2 2026 in Review

Verdence Capital Advisors increased its Stryker (SYK) stake by 435% in Q2 2026, buying an estimated $3.55M and bringing the position to 13,851 shares worth $4.36M. The position accounts for 0.23% of the portfolio, ranked #103.

Verdence Capital Advisors first reported a position in SYK in Q2 2023 and has held it in 13 quarters since. 2,259 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Verdence Capital Advisors held 13,851 shares of Stryker worth $4.36M as of Q2 2026.
  • Verdence Capital Advisors bought 11,260 Stryker shares in Q2 2026, an estimated $3.55M.
  • Stryker made up 0.23% of Verdence Capital Advisors's portfolio in Q2 2026, its #103 holding.
  • Verdence Capital Advisors first reported a position in Stryker in Q2 2023 and has held it in 13 quarters since.
  • 2,259 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.